跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
注射用双羟萘酸帕瑞肽微球 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Pasireotide Pamoate Microspheres for Injection
Approved
化学药品
Pasireotide Pamoate Microspheres for Injection
RECORDATI RARE DISEASES
🇨🇳 National Medical Products Administration
Approval Date
Apr 22, 2025
Approval ID
8jXiBT1REFm
Company
RECORDATI RARE DISEASES
Type
化学药品
Approval Details
Approval Id
8jXiBT1REFm
Approval Number
国药准字HJ20250048
Generic Name
注射用双羟萘酸帕瑞肽微球
Generic Name En
Pasireotide Pamoate Microspheres for Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
20mg（按C₅₈H₆₆N₁₀O₉计）
Reg Date
2025-04-22
Expired Date
2030-04-21
Company Name
RECORDATI RARE DISEASES
Company Detail Path
/organization/recordati-rare-diseases
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 22, 2025
Approval ID
8jXiBT1REFm
Type
化学药品
Back to NMPA Approvals
